Free Trial

Bellecapital International Ltd. Sells 48,385 Shares of Procter & Gamble Company (The) $PG

Procter & Gamble logo with Consumer Staples background

Key Points

  • Bellecapital International Ltd. sold 48,385 shares of Procter & Gamble, reducing its stake by 91.3%, leaving them with 4,636 shares valued at $739,000.
  • A significant increase in holdings was reported by Kingstone Capital Partners, which grew its stake by 655,209.0%, now owning 76 million shares worth nearly $11.83 billion.
  • Procter & Gamble announced a quarterly dividend of $1.0568 per share, representing an annualized dividend of $4.23 with a dividend yield of 2.9%, to be paid on November 17th.
  • Interested in Procter & Gamble? Here are five stocks we like better.

Bellecapital International Ltd. lessened its position in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 91.3% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 4,636 shares of the company's stock after selling 48,385 shares during the period. Bellecapital International Ltd.'s holdings in Procter & Gamble were worth $739,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in the company. Kingstone Capital Partners Texas LLC grew its holdings in Procter & Gamble by 655,209.0% in the 2nd quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company's stock worth $11,832,680,000 after acquiring an additional 76,017,350 shares during the last quarter. Northern Trust Corp boosted its stake in shares of Procter & Gamble by 0.8% during the 1st quarter. Northern Trust Corp now owns 29,644,000 shares of the company's stock valued at $5,051,930,000 after purchasing an additional 248,792 shares in the last quarter. Price T Rowe Associates Inc. MD boosted its stake in shares of Procter & Gamble by 13.0% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company's stock valued at $3,660,737,000 after purchasing an additional 2,466,308 shares in the last quarter. Goldman Sachs Group Inc. boosted its stake in shares of Procter & Gamble by 3.5% during the 1st quarter. Goldman Sachs Group Inc. now owns 17,405,539 shares of the company's stock valued at $2,966,252,000 after purchasing an additional 583,629 shares in the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in shares of Procter & Gamble by 6.3% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 17,293,428 shares of the company's stock valued at $2,947,146,000 after purchasing an additional 1,018,865 shares in the last quarter. Institutional investors own 65.77% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on PG shares. BNP Paribas reaffirmed an "outperform" rating and set a $177.00 target price on shares of Procter & Gamble in a research note on Friday, August 15th. Berenberg Bank lifted their price target on shares of Procter & Gamble from $152.00 to $154.00 and gave the company a "hold" rating in a research report on Wednesday, September 17th. Evercore ISI reissued an "in-line" rating and set a $170.00 price target (down from $190.00) on shares of Procter & Gamble in a research report on Monday, July 14th. UBS Group lowered their price target on shares of Procter & Gamble from $180.00 to $176.00 and set a "buy" rating for the company in a research report on Wednesday, October 8th. Finally, JPMorgan Chase & Co. lowered their price target on shares of Procter & Gamble from $170.00 to $163.00 and set a "neutral" rating for the company in a research report on Friday, October 10th. Eleven research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $172.21.

Get Our Latest Analysis on Procter & Gamble

Insider Activity

In related news, CFO Andre Schulten sold 11,638 shares of the business's stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total transaction of $1,830,308.26. Following the completion of the sale, the chief financial officer directly owned 52,642 shares in the company, valued at approximately $8,279,007.34. The trade was a 18.11% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, COO Shailesh Jejurikar sold 13,039 shares of the company's stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total transaction of $2,050,643.53. Following the completion of the transaction, the chief operating officer owned 28,036 shares of the company's stock, valued at approximately $4,409,221.72. The trade was a 31.74% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 149,763 shares of company stock valued at $23,421,279 over the last three months. Corporate insiders own 0.20% of the company's stock.

Procter & Gamble Stock Down 1.1%

Shares of Procter & Gamble stock opened at $147.45 on Thursday. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.49 and a current ratio of 0.70. The stock has a market capitalization of $345.11 billion, a PE ratio of 22.65, a price-to-earnings-growth ratio of 3.96 and a beta of 0.36. Procter & Gamble Company has a 52-week low of $146.96 and a 52-week high of $180.43. The company has a 50-day simple moving average of $155.04 and a two-hundred day simple moving average of $159.12.

Procter & Gamble (NYSE:PG - Get Free Report) last issued its earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.42 by $0.06. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The business had revenue of $20.89 billion during the quarter, compared to analysts' expectations of $20.79 billion. During the same period in the previous year, the company earned $1.40 earnings per share. The business's revenue for the quarter was up 1.7% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, analysts anticipate that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.

Procter & Gamble Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, November 17th. Stockholders of record on Friday, October 24th will be issued a dividend of $1.0568 per share. This represents a $4.23 annualized dividend and a dividend yield of 2.9%. The ex-dividend date of this dividend is Friday, October 24th. Procter & Gamble's payout ratio is presently 64.98%.

About Procter & Gamble

(Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Recommended Stories

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG - Free Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Procter & Gamble Right Now?

Before you consider Procter & Gamble, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.

While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s New Deal: Is it an Earnings Signal Investors Can’t Ignore?
From $1 to $15: The Rare Earth Stocks Powering Massive Gains
3 Undervalued Energy Stocks Under $20 with Big Potential

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines